Impact of epigallocatechin-3-gallate (EGCG), a broad-spectrum anti-inflammatory, in controlling intestinal factors contributing to inflammatory bowel disease.
Gerald W. Dryden(University of Louisville)
Cited by 0
Related Papers
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease
|Gastroenterology|2016|162
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease
|The American Journal of Human Genetics|2021|44